Saturday 24 February 2018 ,
Saturday 24 February 2018 ,
Latest News
  • Police foil BNP’s black flag prog, Alal held
  • 3 bombs hit Myanmar's Rakhine state
  • BNP may go tough for Khaleda release
  • Myanmar bulldozes scores of Rohingya villages: HRW
  • Vehicle prices go up over high demand
  • Expedite disposal of pending cases
5 February, 2018 00:00 00 AM

Novo Nordisk and Eskayef signs (MoU) to transfer Danish state-of-the-art technology to Bangladesh for advanced insulin manufacturing

Stethoscope desk
Novo Nordisk and Eskayef signs (MoU) to transfer Danish state-of-the-art technology to Bangladesh for advanced insulin manufacturing

As an outcome of a high-level government delegation visit to Denmark in February last year, Novo Nordisk – the world’s largest insulin manufacturer has now agreed to transfer Danish advanced state-of-the-art insulin devices manufacturing technology to Bangladesh.

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given the company experience and capabilities to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries.

Mr Anand Shetty, Managing Director of Novo Nordisk Bangladesh and Ms Simeen Hossain, Managing Director of Eskayef Pharmaceutical Ltd. recently signed a Memorandum of Understanding (MoU) at a local hotel in Dhaka to set-up local manufacturing of human and modern insulin in cartridges in the presence of Zahid Malik, State Minister for Health and Family Welfare Ministry.

Eskayef has emerged as one of the leading pharmaceutical companies in Bangladesh. The state-of-the-art manufacturing facility of Eskayef has been approved by stringent global regulators including UK MHRA, European Medicines Agency, TGA Australia, VMD UK and UNICEF. Eskayef is growing globally and are already exporting their products to different countries in Asia, Africa, Europe and Australia.

Zahid Malik, State Minister for Health and Family Welfare Ministry, said: “Diabetes, one of the non-communicable diseases, poses a big threat to sustainable development. The growing number of patients living with diabetes is in constant need of proper care and timely treatment including the need for quality insulin supply at affordable price.”

Speaking on the occasion, Latifur Rahman, chairman, Transcom Group said: "The Danish state-of-the-art modern insulin manufacturing technology transfer is a matter of pride, not only for Eskayef but for the whole country. It has only been made possible due to Eskayef’s proven track record of strict adherence to quality.

“The partnership will further strengthen the bilateral relation between Denmark and Bangladesh. It is a historic event and Denmark is proud to be a partner and contribute to the advancement of this sector in Bangladesh,” said the Danish Ambassador to Bangladesh Mikael Hemniti Winther.

Lars Bo Smidt, Corporate Vice-President, Finance and Operations for Novo Nordisk’s Africa, Asia, Middle East and Oceania regions; S. M. Shafiuzzaman, General Secretary, Bangladesh Association of Pharmaceutical Industries; Kazi M. Aminul Islam, Executive Chairman, Bangladesh Investment Development Authority; Professor AK Azad Khan, President of Diabetic Association of Bangladesh and Roxana Quader, Additional Secretary (Public Health and World health Organization), Ministry of Health and Family Welfare were present at the programme.

 

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Our cover story this week is on dental disorders. Teeth are a very important part of the human body. They are the body's hardest and most durable…
What are the most common dental problems?

What are the most common dental problems?

Tammy Davenport   Dental problems are never any fun, but the good news is that most of them can be easily prevented. Brushing twice a day, flossing…
Oral pain, tooth pain, and injuries

Oral pain, tooth pain, and injuries

Dentist Steven E. Roth, DMD, answers questions about oral pain, toothaches, and mouth injuries. Question: I had my teeth cleaned yesterday and when I…
WHO on oral health

WHO on oral health

Key facts •    Worldwide, 60–90% of school children and nearly 100% of adults have dental cavities. •    Dental…
Oral surgery

Oral surgery

Impacted teeth Wisdom teeth, otherwise known as third molars, are the last set of teeth to develop. Sometimes these teeth emerge from the gum line and…
Does your child have an iron deficiency?

Does your child have an iron deficiency?

Kadakkal Radhakrishnan, M.D. Iron is an important micronutrient in the human body and an essential nutrient for your little one's development. That…
Brain response to hearing one's own name found to be diminished in adults with autism

Brain response to hearing one's own name found to be diminished in adults with autism

Previously, research has shown that children at risk of an autism diagnosis respond less to hearing their own name. Now, a new study from the research…
FAQ on fatty liver (Hepatic Steatosis)

FAQ on fatty liver (Hepatic Steatosis)

Fatty liver, or hepatic steatosis, is a term that describes the buildup of fat in the liver. It’s normal to have some fat in your liver, but too…
Common mistakes when trying to lose weight

Common mistakes when trying to lose weight

Losing weight can seem very tough. Sometimes you may feel like you are doing everything right and yet unable to achieve satisfying results. It is important…
How contagious is flu?

How contagious is flu?

 Lisa Ryan Even though all we want to do right now is focus our energy on the Olympics (and more specifically, that insane triple axel), we can’t…
New antibiotic family discovered in dirt

New antibiotic family discovered in dirt

US scientists have discovered a new family of antibiotics in soil samples. The natural compounds could be used to combat hard-to-treat infections, the…
Widely used COPD meds tied to increased fracture risk

Widely used COPD meds tied to increased fracture risk

Many patients with chronic obstructive pulmonary disease (COPD) are placed on powerful inhaled corticosteroid therapy to ease symptoms. But new research…
FDA approves of Firvanq (vancomycin) for treatment of Clostridium Difficile associated Diarrhea and S. Aureus Colitis

FDA approves of Firvanq (vancomycin) for treatment of Clostridium Difficile associated Diarrhea and S. Aureus Colitis

CutisPharma announced recently that the US Food and Drug Administration (FDA) has approved Firvanq (vancomycin hydrochloride) for oral solution, for the…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting